Medical device ethics and compliance conference
https://www.pharmacongress.com/wp-content/themes/ipc/brochure/2023Pharma-agenda-20230822.pdf
Both Lafond and Vince (contracted by THTX) will be speaking at a conference with the agenda medical device ethics and compliance.
"Mini Summit 36: Outsourced Compliance Programs:
How to Make them Work?
As corporate budgets shrink amid global economic belt-tightening, life science com-panies, especially start-up companies looking to launch their first or second product, struggle to strike the right balance between economic efficiency and compliance effectiveness. To strike that balance, many companies have turned to outsourcing their compliance function as the right solution. With the COVID pandemic making virtual support a "New Normal" an outsourced compliance solution is more viable than ever. The latest updated Department of Justice Compliance Program Guidance clearly recognizes this as an option. Listen to experienced practitioners and in-house counsel who have implemented this option. They will share their views on how best to do so to be truly effective and cost-efficient from both a legal/compliance and business perspective.
9:00 am
Introduction, Discussion and Q&A
Jocelyn Lafond, LLB, LLM, Vice President, General Counsel and Corporate Secretary, Theratechnologies, Montreal, Quebec, Canada
L. Stephan Vince, JD, LLM, MBA, President and Chief Executive Officer, TRESTLE Compliance; Former Sr. Vice President and Chief Compliance Officer, Warner Chilcot; Former Vice President, Ethics and Compliance Officer, TAP Pharmaceutical, Boston, MA (Moderator)".